Guest Editors
Assoc. Prof. Xiuping Yu
Email: xiuping.yu@lsuhs.edu
Affiliation: Department of Biochemistry & Molecular Biology, LSU Health Shreveport, Shreveport, United States
Homepage:
Research Interests: prostate cancer, urological cancer

Assoc. Prof. Yunshin Albert Yeh
Email: yunshin.yeh@lsuhs.edu
Affiliation: Department of Pathology and Translational Pathobiology, Overton Brooks VA Medical Center and LSU Health Shreveport, Shreveport, United States
Homepage:
Research Interests: prostate, kidney, and urinary bladder cancers

Summary
This Special Issue will highlight recent mechanistic, translational, and therapeutic advances in urological malignancies, such as prostate, bladder, and kidney cancers. We invite original research and focused reviews that deepen mechanistic understanding, identify therapeutic vulnerabilities, and advance precision oncology across urological tumor types. We welcome original research and authoritative reviews that elucidate molecular drivers of tumor initiation, progression, therapy resistance, and clinical translation.
Topics of Interest include:
· Molecular and cellular mechanisms of urological cancer progression
· Genomic, epigenetic, and transcriptomic alterations
· Tumor microenvironment and immune regulation
· Biomarkers and therapeutic targets
· Drug resistance and treatment strategies
· Translational and preclinical models
Keywords
urological cancer, prostate cancer, bladder cancer, kidney cancer